These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3166538)

  • 1. Chronic erosive gastritis--a therapeutic approach with bismuth.
    Malfertheiner P; Stanescu A; Baczako K; Bode G; Ditschuneit H
    Scand J Gastroenterol Suppl; 1988; 142():87-92. PubMed ID: 3166538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
    Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
    Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
    Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E
    J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
    Morris A; Brown P; Ali MR; Lane M; Palmer R
    N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
    McNulty CA
    Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bismuth aluminate in gastroenterology. Therapeutic effects in chronic erosive Campylobacter pylori-associated gastritis].
    Stanescu A; Malfertheiner P; Mayer D; Baczako K; Ditschuneit H
    Fortschr Med; 1989 Oct; 107(29):623-6. PubMed ID: 2680842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter pylori in patients with dyspeptic symptoms and endoscopic evidence of erosion(s).
    Elta GH; Murphy R; Behler EM; Barnett JL; Nostrant TT; Kern S; Appelman H
    Am J Gastroenterol; 1989 Jun; 84(6):643-6. PubMed ID: 2729235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology and therapy of Campylobacter pylori infection].
    Wagner S; Freise J; Bär W; Fritsch S; Schmidt FW
    Dtsch Med Wochenschr; 1989 Mar; 114(11):407-13. PubMed ID: 2707124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
    Menge H; Hofmann J; Gregor M
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():44-6. PubMed ID: 3318192
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphologic changes in chronic active superficial Campylobacter pylori-positive antrum gastritis after treatment with bismuth].
    Sorf M; Krislo V; Gogora M; Masek O
    Vnitr Lek; 1990 Aug; 36(8):759-62. PubMed ID: 2136460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperplastic gastric polyps associated with persistent Helicobacter pylori infection and active gastritis.
    Veereman Wauters G; Ferrell L; Ostroff JW; Heyman MB
    Am J Gastroenterol; 1990 Oct; 85(10):1395-7. PubMed ID: 2220735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of Campylobacter pylori--a causative factor in gastritis?
    McNulty CA
    Scand J Gastroenterol Suppl; 1989; 160():3-6. PubMed ID: 2683021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral bismuth subsalicylate on Campylobacter pylori and on healing and relapse rate of peptic ulcer.
    Eberhardt R; Kasper G
    Rev Infect Dis; 1990; 12 Suppl 1():S115-9. PubMed ID: 2406852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes.
    Berstad A; Alexander B; Weberg R; Serck-Hanssen A; Holland S; Hirschowitz BI
    Gastroenterology; 1988 Sep; 95(3):619-24. PubMed ID: 3294081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens.
    Glupczynski Y; Burette A; Nyst JF; De Prez C; De Koster E; Deltenre M
    Acta Gastroenterol Belg; 1988; 51(4-5):329-37. PubMed ID: 2979039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial.
    Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S
    Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers.
    Iserhard R; Freise J; Wagner S; Bokemeyer B; Weissbrodt H; Fritsch RS; Soudah B; Schmidt FW
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():38-44. PubMed ID: 1982107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.
    Hui WM; Lam SK; Ho J; Ng I; Lau WY; Branicki FJ; Lai CL; Lok AS; Ng MM; Fok J
    Am J Med; 1989 Jun; 86(6A):60-5. PubMed ID: 2660558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.